Cabaletta Bio, Inc. CABA
2.07
(0.09)
(4.17%)
as of 25 Sep
- Market cap
- $373.0M
- P/E
- 0.0×
Follow CABA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
5.79 | 2.95 | 2.77 | 3.60 |
+8 more quarters Free account |
Net Debt/EBITDA |
4.37 | 2.64 | 4.26 | 3.42 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.98 | 0.84 | 0.77 | |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | 0.46 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.27) | (0.38) | (0.44) | (0.34) | |
Cash per Share |
1.49 | 1.04 | 1.67 | 1.56 | |
Shareholders Equity per Share |
1.39 | 0.92 | 1.40 | 1.36 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.39 | 0.92 | 1.40 | 1.36 | |
Free Cash Flow |
(41.51) | (42.56) | (35.55) | (34.59) | |
Working Capital |
191.12 | 80.81 | 88.72 | 118.83 | |
Capital Expenditures |
— | — | (0.20) | (0.08) | |
Net Current Asset Value |
184.90 | 77.48 | 85.84 | 114.27 | |
| Other line items | |||||
Quick Ratio |
5.64 | 2.81 | 2.66 | 3.50 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.27) | (0.38) | (0.44) | (0.34) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
6.50 | 6.44 | 5.78 | 5.22 | |
Average Assets |
240.61 | 156.64 | 175.06 | 197.08 | |
Average Common Equity |
194.54 | 112.43 | 132.19 | 156.85 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates